Maxcyte (MXCT) Free Cash Flow (2020 - 2026)
Maxcyte (MXCT) reported Free Cash Flow of -$8.2 million for Q1 2026, up 45.61% year-over-year from -$5.6 million in Q1 2025, and down 591.39% on a QoQ basis from -$1.2 million in Q4 2025.
Maxcyte (MXCT) has 7 years of Free Cash Flow data on file, last reported at -$8.2 million in Q1 2026.
- Quarterly Free Cash Flow rose 45.61% year-over-year to -$8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.6 million (up 18.29% YoY) and the FY2025 annual result came in at -$34.4 million, down 17.71% from the prior year.
- Free Cash Flow eased to -$8.2 million in Q1 2026 per MXCT's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $9.8 million in Q4 2022 and bottomed at -$21.1 million in Q3 2022.
- The 5-year median for Free Cash Flow is -$8.0 million (2024), against an average of -$6.6 million.
- Peak annual rise in Free Cash Flow reached 572.21% in 2022, while the deepest fall reached 891.32% in 2022.
- Tracing MXCT's Free Cash Flow over 5 years: stood at $9.8 million in 2022, then slumped by 124.73% to -$2.4 million in 2023, then plunged by 227.63% to -$8.0 million in 2024, then jumped by 85.13% to -$1.2 million in 2025, then plunged by 591.39% to -$8.2 million in 2026.
- Per Business Quant, the three latest MXCT Free Cash Flow figures stand at -$8.2 million (Q1 2026), -$1.2 million (Q4 2025), and -$7.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | -8.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.19 Mn |
| Mar 31, 2026 | -8.19 Mn |
| Dec 31, 2025 | -1.19 Mn |
| Dec 31, 2025 | -1.19 Mn |
| Sep 30, 2025 | -7.76 Mn |
| Sep 30, 2025 | -7.76 Mn |
| Jun 30, 2025 | -10.44 Mn |
| Jun 30, 2025 | -10.44 Mn |
| Mar 31, 2025 | -15.06 Mn |
| Mar 31, 2025 | -15.06 Mn |
| Dec 31, 2024 | -7.97 Mn |
| Dec 31, 2024 | -7.97 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Jun 30, 2024 | -4.90 Mn |
| Jun 30, 2024 | -4.90 Mn |
| Mar 31, 2024 | -10.58 Mn |
| Mar 31, 2024 | -10.58 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | -8.03 Mn |
| Sep 30, 2023 | -8.03 Mn |
| Jun 30, 2023 | -9.04 Mn |
| Jun 30, 2023 | -9.04 Mn |
| Mar 31, 2023 | -5.88 Mn |
| Mar 31, 2023 | -5.88 Mn |
| Dec 31, 2022 | 9.83 Mn |
| Dec 31, 2022 | 9.83 Mn |
| Sep 30, 2022 | -21.13 Mn |
| Sep 30, 2022 | -21.13 Mn |
| Jun 30, 2022 | 5.84 Mn |
| Jun 30, 2022 | 5.84 Mn |
| Mar 31, 2022 | -9.69 Mn |
| Mar 31, 2022 | -9.69 Mn |
| Dec 31, 2021 | -2.08 Mn |
| Dec 31, 2021 | -2.08 Mn |
| Sep 30, 2021 | -2.13 Mn |
| Sep 30, 2021 | -2.13 Mn |
| Jun 30, 2021 | -5.64 Mn |
| Jun 30, 2021 | -5.64 Mn |
| Mar 31, 2021 | -4.66 Mn |
| Mar 31, 2021 | -4.66 Mn |
| Dec 31, 2020 | -269,800.00 |
| Dec 31, 2020 | -269,800.00 |
| Sep 30, 2020 | -1.49 Mn |
| Sep 30, 2020 | -1.49 Mn |